Prestige Consumer Healthcare (PBH) Other Operating Expenses (2011 - 2025)
Prestige Consumer Healthcare (PBH) posted quarterly Other Operating Expenses of $45.2 million for Q4 2025, up 5.36% year-over-year from $42.9 million in Q4 2024, and up 3.04% quarter-over-quarter from $43.9 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Other Operating Expenses (2011 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Other Operating Expenses history runs 14 years deep, the most recent figure standing at $45.2 million for Q4 2025.
- In Q4 2025, Other Operating Expenses rose 5.36% year-over-year to $45.2 million; the TTM figure through Dec 2025 stood at $183.7 million (up 3.13% YoY), while the FY2025 annual figure was $189.5 million, up 7.74% from the prior year.
- Other Operating Expenses for Q4 2025 stood at $45.2 million, up from $43.9 million in the prior quarter.
- The five-year high for Other Operating Expenses was $407.1 million in Q1 2023, with the low at $36.7 million in Q4 2022.
- The 5-year median for Other Operating Expenses is $45.2 million (2021), against an average of $63.1 million.
- The sharpest annual moves came in 2023 and 2024: Other Operating Expenses jumped 811.05% in 2023, then tumbled 89.39% in 2024.
- Prestige Consumer Healthcare's Other Operating Expenses stood at $46.5 million in 2021, then fell by 21.09% to $36.7 million in 2022, then climbed by 22.96% to $45.1 million in 2023, then retreated by 4.87% to $42.9 million in 2024, then rose by 5.36% to $45.2 million in 2025.
- Business Quant data shows PBH's Other Operating Expenses at $45.2 million in Q4 2025, $43.9 million in Q3 2025, and $40.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | Prestige Consumer Healthcare | 2.44 Bn | 2.38 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 45.20 Mn |
| Sep 30, 2025 | 43.87 Mn |
| Jun 30, 2025 | 40.12 Mn |
| Mar 31, 2025 | 54.53 Mn |
| Dec 31, 2024 | 42.91 Mn |
| Sep 30, 2024 | 46.98 Mn |
| Jun 30, 2024 | 45.07 Mn |
| Mar 31, 2024 | 43.20 Mn |
| Dec 31, 2023 | 45.10 Mn |
| Sep 30, 2023 | 45.77 Mn |
| Jun 30, 2023 | 41.79 Mn |
| Mar 31, 2023 | 407.10 Mn |
| Dec 31, 2022 | 36.68 Mn |
| Sep 30, 2022 | 50.19 Mn |
| Jun 30, 2022 | 46.39 Mn |
| Mar 31, 2022 | 44.68 Mn |
| Dec 31, 2021 | 46.48 Mn |
| Sep 30, 2021 | 46.90 Mn |
| Jun 30, 2021 | 45.20 Mn |
| Mar 31, 2021 | 44.73 Mn |